Crossmark

99mTc-pertechnetate thyroid scintigraphy predicts clinical outcomes in personalized radioiodine treatment for Graves’ disease

Crossref DOI link: https://doi.org/10.1016/j.remnie.2018.07.003

Published Print: 2018-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lina, Zhao

Wenqi, Zhang

Yubo, Xin

Qiang, Wen

Lin, Bail

Feng, Guan

Bin, Ji
License Information

Text and Data Mining valid from 2018-11-01
More Information

This article is maintained by: Elsevier

Article Title: 99mTc-pertechnetate thyroid scintigraphy predicts clinical outcomes in personalized radioiodine treatment for Graves’ disease

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2018.07.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2018.04.005

Content Type: article

Copyright: © 2018 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.